Page 117 - CPG - Clinical Practice Guidelines - Management of Cancer Pain

Management of Cancer Pain (Second Edition)

NCCN National Comprehensive Cancer Network
NMDA N-methyl-D-aspartate
NNH number needed to harm
NNT number needed to treat
156 1XPHULF 5DWLQJ 6FDOH
156 1XPHULF 5DWLQJ 6FDOH
16$,'V QRQVWHURLGDO DQWL LQÀDPPDWRU\ GUXJV
OD daily
OMED oral morphine equivalent daily dose
ONJ osteonecrosis of the jaw
OR odds ratio
ORT Opioid Risk Tool
OTFC oral transmucosal fentanyl citrate
PAINAD Pain Assessment in Advanced Dementia tool
3)( SDLQ ÀDUH HIIHFW
PO by mouth
4R/ TXDOLW\ RI OLIH
RANK receptor activator of nuclear factor kappa beta
RCT randomised controlled trial
RD risk difference
RR risk ratio
6$(V VHYHUH DGYHUVH HYHQWV
6%57 VWHUHRWDFWLF ERG\ UDGLRWKHUDS\
6& VXEFXWDQHRXV
6( VLGH HIIHFWV
6+* VXSHULRU K\SRJDVWULF SOH[XV
6NRIs selective norepinephrine reuptake inhibitors
62$33 5 6FUHHQHU DQG 2SLRLG $VVHVVPHQW IRU 3DWLHQWV ZLWK 3DLQ 5HYLVHG
65 VXVWDLQHG UHOHDVH
65( VNHOHWDO UHODWHG HYHQWV
60' VWDQGDUGLVHG PHDQ GLIIHUHQFH
TD transdermal
7'6 WKUHH WLPHV D GD\
7(16 7UDQVFXWDQHRXV (OHFWULFDO 1HUYH 6WLPXODWLRQ
7PD[ WLPH WR SHDN GUXJ FRQFHQWUDWLRQ
9$6 9LVXDO $QDORJXH 6FDOH
956 9HUEDO 5DWLQJ 6FDOH
WHO World Health Organisation
WMD Weighted mean difference
6P 6P OH[LGURQDP
186Re rhenium (186Re) obisbemeda
188Re Rhenium-188
223Ra Radium-223

99

e-cpg inside text-Cancer pain-25/5/24.indd 99 09/08/2024 12:09 AM